Foreword

Asia Goes Global

Patents and Global Drug Development

US patent laws enable a patent holder to obtain damages as a result of the use of a non-infringing product that is exported from the USA and used in another country as part of a US patented process.

Introduction

Pharmacoeconomic Requirements in Asia

Pharmacoeconomic guidelines have now been developed in Korea and it is likely that pharmacoeconomic evaluations will increasingly influence drug funding across the region over the coming decade. Peter Davey discusses the potential implications.

The Industry in Figures

Going for Growth in China

With China on target to join the world's leading pharmaceutical markets in the near future, Ray Hil highlights the factors that challenge success in this market, and the opportunities for pharmaceutical companies that tailor their sales and marketing effectively.

Outsourcing

Chinese Competitiveness in a Global Context

The emerging markets - Central and Eastern Europe, India and China - are attracting increasing attention both as future markets and as sources for R&D. Of these, China is the one that appears to be pharma's greatest opportunity for growth.

Outsourcing opportunities in China

The global pharma industry is increasingly outsourcing its production processes to service providers in developing countries. China is a major target due to its lower cost structure. William Xia Guo explains how his company aims to become one of the leading providers of drug development outsourcing services.

Clinical Trials

Developing Opportunities

Adoption of best project management and drug development practices have driven significant changes within clinical trials in Asia and Eastern Europe. Eric Morfin discusses the many opportunities now available in these new and growing areas.

Lab Technology & Equipment

Proteomics

From Technology to Anti-Cancer Compounds

There has been a significant progress in the systems biology field during the last decade. Sudhir Sahasrabudhe explains how his company's application of proteomics technologies has resulted in the identification of novel disease targets, drug candidates and biological markers predictive of drug response.

Manufacturing & Processing

Compliance with GMPs During Development

GMPs are necessary for the manufacture of biopharmaceuticals that are administered to patients enrolled in clinical trials. Gail Sofer discusses the approaches for compliance in the areas of cell banking, cell culture and downstream processing.

Biopharma in Japan

Japanese pharmaceutical companies have struggled to find a way into the global marketplace. According to Tadayoshi Kawasaki, with government support, it won't be long before Japan makes its presence felt worldwide in the development and manufacturing of biopharmaceuticals.

Advertorial

Manufacturing & Processing - Serving India and Beyond

Having gained a strong foothold in India's domestic sector, one Haryana-based company specialising in super speciality injectable drugs is working towards expanding its place in the world pharmaceuticals market.

Advertorial

Round Vibrating Screening

With high product quality, continuous innovation and improvement and over 70,000 unit sales in over two decades, Asia's largest separator manufacturer has proved its strength in providing the very best sieving machines.

Chemicals & Raw Materials

Meeting Singapore's Chemical Needs

The pharmaceuticals industry makes a significant contribution to Singapore's economy. To strengthen this position and to foster future development, the Institute of Chemical and Engineering Sciences was established. Professors Keith Carpenter and KC Nicolaou talk about the institute's future aims.

Pharmaceutical Manufacturing in Singapore

As a thriving location with a proven track record in pharmaceutical manufacturing, Singapore has built up world-class capabilities throughout the drug-making process. Yeoh Keat Chuan explains how his country aims to strengthen its capabilities to become the biomedical centre of Asia.

Packaging

Drugs, Lies and Regulations

Pharmaceutical counterfeiting is increasing, potentially putting the safety, possibly lives, of millions of patients at risk. Julian Mount explains what his company is doing to ensure and enhance patient safety.